Skip to main content
. 2020 Nov 24;12(3):8867. doi: 10.4081/or.2020.8867

Table 2.

Microbial findings in 124 patients with PJI.

All PJI, n=124 (%) DTT PJI, n=28 (%) Non-DTT PJI, n=95 (%)
Monomicrobial PJI 93 (74.9) 10 (35.6) 83 (87.3)
Gram-positive bacteria 72(58) 6 (21.4) 66 (69.4)
    Staphylococcus spp. 53 (42.7) 6 (21.4) 47 (49.4)
    Staphylococcus aureus 31(25) 1 (3.5) 30 (31.5)
    Staphylococcus epidermidis 16 (12.9) 5 (17.8) 11 (11.5)
    Coagulase-negative staphylococci 6 (4.8) - 6 (6.3)
    Streptococcus spp. 9 (7.2) - 9 (9.4)
    Enterococcus spp. 4 (3.2) - 4 (4.2)
    Other1 6 (4.8) - 6 (6,3)
Gram-negative bacteria 21 (16.9) 4 (14.3) 17 (17.9)
    Escherichia coli 10(8) 4 (14.3) 6 (6,3)
    Enterobactericaceae spp.2 9 (7.2) - 9 (9.4)
    Pseudomonas aeruginosa 2 (1.6) - 2 (2.1)
Polymicrobial PJI 30 (24.2) 18 (64.3) 12 (12.6)
Negative culture 1 (0.8) - -

Data presented as absolute Number (Percentage). Abbreviations: PJI periprosthetic joint infection, DTT difficult-to-treat. 1Including Corynebacterium spp. (n=3), Micrococcus spp. (n=2), Pediococcus spp. 2Including Enterobacter spp. (n=4), Klebsiella spp. (n=3), Citrobacter spp., Serratia marcescens.